Bolstering Sikkim’s growth
Sikkim needs to re-strategise to develop newer capabilities and scale-up its growth to retain its position as a pharma hub
For the last few years, Sikkim has proven itself as an investor-friendly destination, with many pharma companies setting up their shop there. Several major pharma companies such as Cipla, Sun Pharma, ZydusCadila, Alembic, IPCA, Alkem Lab, Intas Pharma, Torrent Pharma and Unichem, with their facilities in the state have been able to sustain themselves with fiscal incentives and industry-friendly policies like the ‘North East Industrial and Investment Promotion Policy (NEIIPP), 2007, giving a boost to the sector.
In a cost-competitive environment, when the pharma industry is thriving to grow and looking forward to a sustainable business model, pharma stakeholders are looking for avenues which can accelerate their growt